文献速递肺外科心外重症与机械循环支持

12岁及以上儿科患者体外膜氧合桥接肺移植的结局

Outcome of Bridge to Lung Transplantation With Extracorporeal Membrane Oxygenation in Pediatric Patients 12 Years and Older.
PubMed 文献 · Ann Thorac Surg · 2020-11-18

该研究基于UNOS数据回顾2005-2016年12-18岁首次肺移植患者,比较ECMO桥接组(16例)与非桥接组(375例)的结局。桥接组30天生存率88%,1年与3年生存率与非桥接组相似,尽管桥接组病情更重、等待时间更短、肺分配评分更高。结论认为ECMO桥接肺移植在该人群是合理策略。

要点

  • ECMO桥接组30天生存率88%,1年与3年生存率与非桥接组无显著差异。
  • 桥接组等待时间更短、肺分配评分更高、更可能接受成人供肺。
  • 桥接组移植后住院时间更长,且是3年死亡的唯一预测因素。

核心结论

  • 对于≥12岁儿科患者,ECMO桥接肺移植是合理策略,手术死亡率可接受,1年和3年生存率与非桥接患者相似。

研究设计与样本

  • 回顾性队列研究,查询UNOS数据库2005-2016年12-18岁首次肺移植患者,分为ECMO桥接组(16例)和非桥接组(375例)。

主要发现

  • 桥接组等待时间更长者死亡率更高,且更可能接受成人供肺。

临床怎么用

  • 对于≥12岁病情危重的儿科肺移植候选者,可考虑ECMO桥接以缩短等待时间并增加接受成人供肺的机会。
  • 桥接患者移植后住院时间较长,需关注术后管理及长期生存预测因素。

局限性

  • 桥接组样本量小(16例),可能影响统计效能。
  • 回顾性数据库研究,存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a reluctance to using extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation in the pediatric population. Pediatric patients between ages 12 and 18 years are eligible for acuity-based lung transplantation using the Lung Allocation Score and may be suitable for adult allografts, increasing the donor pool and thus leading to a successful bridge to lung transplantation. METHODS: The United Network for Organ Sharing dataset was queried for primary lung transplantation in pediatric patients (12-18 years) from 2005 to 2016. Groups were divided into those who were on ECMO (bridged [BG]) and not on ECMO (nonbridged [NBG]) at the time of listing for lung transplant. RESULTS: The groups comprised 16 BG and 375 NBG patients. Fourteen BG patients (88%) survived the first 30 days. One-year (83.3% vs 86.2%, P = .78) and 3-year (66.7% vs 55.1%, P = .57) survivals were similar in the BG and NBG groups, respectively. Donors in the BG group were more likely to be adults. The median wait-list times were shorter (10.5 [interquartile range {IQR}, 11] vs 93 [IQR, 221] days, P < .001), with a higher Lung Allocation Score (89.8 vs 36.6, P < .001) and similar median ischemic times (5.19 [IQR, 2.32] vs 5.34 [IQR, 1.92] hours, P = .85) in the BG group compared with the NBG group. The median post-transplant length of stay was longer in the BG group (33 [IQR, 31] vs 17 [IQR, 12] days, P = .007) and was the only factor predictive of 3-year mortality. Longer wait-list time had a higher mortality in the BG group. CONCLUSIONS: ECMO as a bridge to lung transplantation is a reasonable strategy in pediatric patients aged ≥ 12 years with acceptable operative mortality and similar 1- and 3-year survival compared with nonbridged patients despite higher acuity. Bridged patients were more likely to receive adult donor lungs.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sainathan S, Ryan J, Sharma M, et al. Outcome of Bridge to Lung Transplantation With Extracorporeal Membrane Oxygenation in Pediatric Patients 12 Years and Older. Ann Thorac Surg. 2020. PMID: 33217402. doi:10.1016/j.athoracsur.2020.08.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。